The Asia Pacific Veterinary Orthopedic Implants Market would witness market growth of 5.2% CAGR during the forecast period (2022-2028).
A game-changer for the veterinary orthopaedic implant market is the government's expanding support for veterinary treatment. The veterinary orthopaedic implant market is growing as a consequence of initiatives and government financing from numerous organisations and government departments. Due to the numerous advantages they provide, the use of bioabsorbable implants in veterinary orthopaedic procedures is gradually gaining momentum.
Key players in the veterinary orthopaedic implant market are heavily concentrating on research & development efforts, therefore new discoveries are still to come. The need for effective treatment options is being driven by an increase in osteoarthritis cases in animals. The number of animal-automobile collisions (AVCs) is on the rise as human populations expand and road networks are built in areas that are also home to wildlife.
Millions of animals across many taxonomic groups are killed each year by AVCs. Warning signs, animal crossing structures, and other kinds of fencing are just some of the mitigating measures that have been developed and put into place around the world to cut down on AVCs, but none of them have proven to be completely successful.
In recent years, India's animal health business has evolved from its former focus on disease prevention and treatment to become a full-service health professional and support system. Development in the veterinary healthcare industry can be attributed to the rising value of livestock animals. In order to effectively treat various diseases and injuries in animals, the number of retail and hospital pharmacies in India stocking veterinary medications, nutritional supplements, pet vaccines, etc. has exploded in recent years. The market for veterinary orthopaedic implants is expected to expand rapidly in the Asia Pacific area as a result of increased consumer awareness of the importance of animal health and the enormous market potential in the region.
The China market dominated the Asia Pacific Veterinary Orthopedic Implants Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $10,632.3 Thousands by 2028. The Japan market is estimated to grow a CAGR of 4.6% during (2022 - 2028). Additionally, The India market would experience a CAGR of 5.9% during (2022 - 2028).
Based on End User, the market is segmented into Hospital, Clinics, and Others. Based on Product Type, the market is segmented into Plates, Screws, and Others. Based on Application, the market is segmented into Cruciate Ligament Rupture, Bone Fractures, Hip Dysplasia, Elbow Dysplasia, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Veterinary Orthopedic Implants Market is Projected to reach USD 136.8 Million by 2028, at a CAGR of 4.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vimian Group AB, Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG, Johnson & Johnson, OrthoMed, Inc., Arthrex, Inc., Auxein Medical Pvt. Ltd., Ortho Max Mfg. Co. Pvt. Ltd., BLUESAO Co., Ltd., and Narang Medical Limited.
By End User
By Product Type
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 